Friday, October 23, 2026

Fomento Economico Mexicano S.A.B. De C.V. Stock Is 9% Up So Far On Thursday

ViaNews Editorial Team

February 16, 2023

Fomento Economico Mexicano S.A.B. De C.V. Stock Is 9% Up So Far On Thursday

(VIANEWS) - Shares of Fomento Economico Mexicano S.A.B. de C.V. (NYSE: FMX) rose 9.2% to $94.79 at 13:00 EST on Thursday, after five successive sessions in a row of gains. NYSE is sliding 0.41% to $15,950.91, after two sequential sessions in a row of losses. This seems, at the moment, a somewhat bearish trend trading session today.

Fomento Economico Mexicano S.A.B. de C.V.'s last close was $86.80, 1.23% under its 52-week high of $87.88.

About Fomento Economico Mexicano S.A.B. de C.V.

Fomento Económico Mexicano, S.A.B. de C.V., through its subsidiaries, operates as a bottler of Coca-Cola trademark beverages. The company produces, markets, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, Argentina, and Uruguay. It also operates small-box retail chain stores in Mexico, Colombia, Peru, Chile, and Brazil under the OXXO name; retail service stations for fuels, motor oils, lubricants, and car care products under the OXXO GAS name in Mexico; and drugstores in Chile, Colombia, Ecuador, and Mexico under the Cruz Verde, Fybeca, SanaSana, YZA, La Moderna, and Farmacon names. In addition, the company is involved in the production and distribution of chillers, commercial refrigeration equipment, plastic boxes, food processing, and preservation and weighing equipment; and provision of logistic transportation, distribution and maintenance, point-of-sale refrigeration, and plastics solutions, as well as distribution platform for cleaning products and consumables. As of December 31, 2021, it operated 20,431 OXXO stores; 3,652 drugstores; and 567 OXXO GAS service stations. Fomento Económico Mexicano, S.A.B. de C.V. was founded in 1890 and is based in Monterrey, Mexico.

Earnings Per Share

As for profitability, Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months EPS of $-0.27.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.66%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Fomento Economico Mexicano S.A.B. de C.V.'s stock is considered to be oversold (<=20).

Volume

Today's last reported volume for Fomento Economico Mexicano S.A.B. de C.V. is 2173974 which is 279.81% above its average volume of 572373.

More news about Fomento Economico Mexicano S.A.B. de C.V. (FMX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,475 source documents archived
Query this data → isubstrate.com